NasdaqGS - Delayed Quote USD

Cross Country Healthcare, Inc. (CCRN)

Compare
18.16
-0.03
(-0.16%)
At close: January 14 at 4:00:01 PM EST
18.16
0.00
(0.00%)
After hours: January 14 at 4:20:00 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 315.12M
Earnings 2.56M
Q4'23
Q1'24
Q2'24
Q3'24
0
100M
200M
300M
400M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

14.00 Low
17.46 Average
18.16 Current
18.61

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 8678
Avg. Estimate 0.120.110.530.59
Low Estimate 0.110.060.510.38
High Estimate 0.150.20.540.79
Year Ago EPS 0.290.192.230.53

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 8688
Avg. Estimate 306.17M304.95M1.34B1.25B
Low Estimate 304.97M296.52M1.34B1.2B
High Estimate 307.84M309.7M1.34B1.31B
Year Ago Sales 414.04M379.17M2.02B1.34B
Sales Growth (year/est) -26.05%-19.58%-33.64%-6.48%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.270.170.130.1
EPS Actual 0.290.190.10.12
Difference 0.020.02-0.030.02
Surprise % 5.89%12.06%-24.68%25.76%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.110.110.530.55
7 Days Ago 0.120.110.530.59
30 Days Ago 0.120.120.530.59
60 Days Ago 0.130.130.520.7
90 Days Ago 0.130.130.520.7

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 111--
Up Last 30 Days 111--
Down Last 7 Days --2--1
Down Last 30 Days 1312

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CCRN -58.37%-41.80%-76.09%10.63%
S&P 500 8.58%11.41%13.97%13.43%

Upgrades & Downgrades

Downgrade Barrington Research: Outperform to Market Perform 12/10/2024
Maintains Truist Securities: Hold to Hold 12/5/2024
Maintains Benchmark: Buy to Buy 11/7/2024
Maintains Truist Securities: Hold to Hold 10/21/2024
Maintains Barrington Research: Outperform to Outperform 8/8/2024
Maintains Truist Securities: Hold to Hold 8/1/2024

Related Tickers